BACKGROUND: Recessive mutations in the NPHS1 gene encoding nephrin account for approximately 40% of infants with congenital nephrotic syndrome (CNS). CNS is defined as steroid-resistant nephrotic syndrome (SRNS) within the first 90 days of life. Currently, more than 119 different mutations of NPHS1 have been published affecting most exons. METHODS: We here performed mutational analysis of NPHS1 in a worldwide cohort of 67 children from 62 different families with CNS. RESULTS: We found bi-allelic mutations in 36 of the 62 families (58%) confirming in a worldwide cohort that about one-half of CNS is caused by NPHS1 mutations. In 26 families, mutations were homozygous, and in 10, they were compound heterozygous. In an additional nine patients from eight families, only one heterozygous mutation was detected. We detected 37 different mutations. Nineteen of the 37 were novel mutations (approximately 51.4%), including 11 missense mutations, 4 splice-site mutations, 3 nonsense mutations and 1 small deletion. In an additional patient with later manifestation, we discovered two further novel mutations, including the first one affecting a glycosylation site of nephrin. CONCLUSIONS: Our data hereby expand the spectrum of known mutations by 17.6%. Surprisingly, out of the two siblings with the homozygous novel mutation L587R in NPHS1, only one developed nephrotic syndrome before the age of 90 days, while the other one did not manifest until the age of 2 years. Both siblings also unexpectedly experienced an episode of partial remission upon steroid treatment.
BACKGROUND: Recessive mutations in the NPHS1 gene encoding nephrin account for approximately 40% of infants with congenital nephrotic syndrome (CNS). CNS is defined as steroid-resistant nephrotic syndrome (SRNS) within the first 90 days of life. Currently, more than 119 different mutations of NPHS1 have been published affecting most exons. METHODS: We here performed mutational analysis of NPHS1 in a worldwide cohort of 67 children from 62 different families with CNS. RESULTS: We found bi-allelic mutations in 36 of the 62 families (58%) confirming in a worldwide cohort that about one-half of CNS is caused by NPHS1 mutations. In 26 families, mutations were homozygous, and in 10, they were compound heterozygous. In an additional nine patients from eight families, only one heterozygous mutation was detected. We detected 37 different mutations. Nineteen of the 37 were novel mutations (approximately 51.4%), including 11 missense mutations, 4 splice-site mutations, 3 nonsense mutations and 1 small deletion. In an additional patient with later manifestation, we discovered two further novel mutations, including the first one affecting a glycosylation site of nephrin. CONCLUSIONS: Our data hereby expand the spectrum of known mutations by 17.6%. Surprisingly, out of the two siblings with the homozygous novel mutation L587R in NPHS1, only one developed nephrotic syndrome before the age of 90 days, while the other one did not manifest until the age of 2 years. Both siblings also unexpectedly experienced an episode of partial remission upon steroid treatment.
Authors: Ivo Quack; L Christian Rump; Peter Gerke; Inga Walther; Tobias Vinke; Oliver Vonend; Thomas Grunwald; Lorenz Sellin Journal: Proc Natl Acad Sci U S A Date: 2006-09-12 Impact factor: 11.205
Authors: Rainer G Ruf; Michael Schultheiss; Anne Lichtenberger; Stephanie M Karle; Isabella Zalewski; Bettina Mucha; Anne Schulze Everding; Thomas Neuhaus; Ludwig Patzer; Christian Plank; Johannes P Haas; Fatih Ozaltin; Anita Imm; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt Journal: Kidney Int Date: 2004-08 Impact factor: 10.612
Authors: Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt Journal: J Am Soc Nephrol Date: 2004-03 Impact factor: 10.121
Authors: Nina Jones; Ivan M Blasutig; Vera Eremina; Julie M Ruston; Friedhelm Bladt; Hongping Li; Haiming Huang; Louise Larose; Shawn S-C Li; Tomoko Takano; Susan E Quaggin; Tony Pawson Journal: Nature Date: 2006-03-08 Impact factor: 49.962
Authors: Friedhelm Hildebrandt; Saskia F Heeringa; Franz Rüschendorf; Massimo Attanasio; Gudrun Nürnberg; Christian Becker; Dominik Seelow; Norbert Huebner; Gil Chernin; Christopher N Vlangos; Weibin Zhou; John F O'Toole; Bethan E Hoskins; Matthias T F Wolf; Bernward G Hinkes; Hassan Chaib; Shazia Ashraf; Dominik S Schoeb; Bugsu Ovunc; Susan J Allen; Virginia Vega-Warner; Eric Wise; Heather M Harville; Robert H Lyons; Joseph Washburn; James Macdonald; Peter Nürnberg; Edgar A Otto Journal: PLoS Genet Date: 2009-01-23 Impact factor: 5.917
Authors: Eugenel B Espiritu; Huajun Jiang; Sophie Moreau-Marquis; Mara Sullivan; Kunimasa Yan; Donna Beer Stolz; Matthew G Sampson; Neil A Hukriede; Agnieszka Swiatecka-Urban Journal: J Biol Chem Date: 2019-05-31 Impact factor: 5.157
Authors: Markus M Rinschen; Ann-Kathrin Hoppe; Florian Grahammer; Martin Kann; Linus A Völker; Eva-Maria Schurek; Julie Binz; Martin Höhne; Fatih Demir; Milena Malisic; Tobias B Huber; Christine Kurschat; Jayachandran N Kizhakkedathu; Bernhard Schermer; Pitter F Huesgen; Thomas Benzing Journal: J Am Soc Nephrol Date: 2017-07-19 Impact factor: 10.121